The Cohorts · Quarterly vintage
Inception 2026-04-01 · 0.3 years held
Q2 2026 · Top 5.
On 2026-04-01, these 5 businesses were the 5most-undervalued names in our coverage universe by Mr. Market's protocol. We've held them, equal-weighted, since.
Q2 2026 · Top 5 · since inception
+9.5%
CAGR 30.3% annualised
S&P 500 · since inception
+18.0%
CAGR 61.7% annualised
Spread
-8.5%
This cohort has trailed the index.
Other cohorts at the same inception
The constituents.
Ranked, on the inception date, by Δ% to intrinsic value. Each holding is equal-weighted at 20.0% of the portfolio.
| Rank | Ticker | Entry price | Entry IV | Entry Δ% | Current price | Return | Contribution | |
|---|---|---|---|---|---|---|---|---|
| 1 | JPM | $292.56 | $3,772.50 | +1194.8% | $357.52 | +22.2% | +4.4% | Read → |
| 2 | ADBE | $241.37 | $1,714.15 | +553.2% | $257.49 | +6.7% | +1.3% | Read → |
| 3 | BAC | $49.02 | $300.21 | +519.0% | $62.90 | +28.3% | +5.7% | Read → |
| 4 | OXY | $61.94 | $379.10 | +485.9% | $55.09 | -11.1% | -2.2% | Read → |
| 5 | META | $578.69 | $3,211.65 | +461.9% | $587.94 | +1.6% | +0.3% | Read → |
Biggest contributors
Where the cohort earned its keep.
- BAC · $49.02 → $62.90+28.3%
- JPM · $292.56 → $357.52+22.2%
- ADBE · $241.37 → $257.49+6.7%
Biggest detractors
Where the protocol got it wrong.
- OXY · $61.94 → $55.09-11.1%